In his new blog, Neuralstem's President and CEO Richard Garr writes about the company's Phase II ALS stem cell trial.
http://www.accesswire.com/viewarticle.aspx?id=410137
http://www.accesswire.com/viewarticle.aspx?id=410137
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment